Cargando...
Novel therapeutic approaches for the treatment of castration-resistant prostate cancer()
Prostate cancer is a leading cause of cancer death in men in developed countries. Once the tumor has achieved a castration-refractory metastatic stage, treatment options are limited with the average survival of patients ranging from two to three years only. Recently, new drugs for treatment of castr...
Gardado en:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Pergamon
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3834152/ https://ncbi.nlm.nih.gov/pubmed/23792785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsbmb.2013.06.002 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|